Trial · NCT02410772
Adverse events237
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 237
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Neutropenia | Blood and lymphatic system disorders | Regimen 1 (2HRZE/4HR) | 48 | 825 | 51 |
| other | Neutropenia | Blood and lymphatic system disorders | Regimen 2 (2HPZ/2HP) | 34 | 835 | 39 |
| other | Neutropenia | Blood and lymphatic system disorders | Regimen 3 (2HPMZ/2HPM) | 56 | 846 | 57 |
| other | Hepatitis | Hepatobiliary disorders | Regimen 1 (2HRZE/4HR) | 26 | 825 | 31 |
| other | Hepatitis | Hepatobiliary disorders | Regimen 2 (2HPZ/2HP) | 27 | 835 | 31 |
| other | Hepatitis | Hepatobiliary disorders | Regimen 3 (2HPMZ/2HPM) | 38 | 846 | 40 |
| serious | Anemia | Blood and lymphatic system disorders | Regimen 1 (2HRZE/4HR) | 0 | 825 | 0 |
| serious | Anemia | Blood and lymphatic system disorders | Regimen 2 (2HPZ/2HP) | 1 | 835 | 1 |
| serious | Anemia | Blood and lymphatic system disorders | Regimen 3 (2HPMZ/2HPM) | 0 | 846 | 0 |
| serious | Leukopenia | Blood and lymphatic system disorders | Regimen 1 (2HRZE/4HR) | 0 | 825 | 0 |
| serious | Leukopenia | Blood and lymphatic system disorders | Regimen 2 (2HPZ/2HP) | 0 | 835 | 0 |
| serious | Leukopenia | Blood and lymphatic system disorders | Regimen 3 (2HPMZ/2HPM) | 1 | 846 | 1 |
| serious | Lymphopenia | Blood and lymphatic system disorders | Regimen 1 (2HRZE/4HR) | 0 | 825 | 0 |
| serious | Lymphopenia | Blood and lymphatic system disorders | Regimen 2 (2HPZ/2HP) | 0 | 835 | 0 |
| serious | Lymphopenia | Blood and lymphatic system disorders | Regimen 3 (2HPMZ/2HPM) | 1 | 846 | 1 |
| serious | Neutropenia | Blood and lymphatic system disorders | Regimen 1 (2HRZE/4HR) | 3 | 825 | 3 |
| serious | Neutropenia | Blood and lymphatic system disorders | Regimen 2 (2HPZ/2HP) | 1 | 835 | 1 |
| serious | Neutropenia | Blood and lymphatic system disorders | Regimen 3 (2HPMZ/2HPM) | 2 | 846 | 2 |
| serious | Thrombotic Thrombocytopenic Purpura | Blood and lymphatic system disorders | Regimen 1 (2HRZE/4HR) | 0 | 825 | 0 |
| serious | Thrombotic Thrombocytopenic Purpura | Blood and lymphatic system disorders | Regimen 2 (2HPZ/2HP) | 0 | 835 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02410772/events